AZoLifeSciences on MSN
Combating Influenza A Virus with CRISPR and Human Lung Organ Chips
The Influenza A virus (IAV) has been the cause of six major flu pandemics, responsible for 50 to 100 million deaths globally.
The firm will use the funds to test its NaPi2b-targeted ADC in earlier lines of treatment and across tumor types, and another ADC in 5T4-expressing solid tumors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback